GoalVest Advisory LLC Purchases 124 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

GoalVest Advisory LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,248 shares of the healthcare conglomerate’s stock after buying an additional 124 shares during the quarter. GoalVest Advisory LLC’s holdings in UnitedHealth Group were worth $1,899,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. BCGM Wealth Management LLC increased its stake in shares of UnitedHealth Group by 2.8% during the 3rd quarter. BCGM Wealth Management LLC now owns 3,715 shares of the healthcare conglomerate’s stock worth $2,172,000 after purchasing an additional 100 shares during the last quarter. Schear Investment Advisers LLC increased its stake in shares of UnitedHealth Group by 12.5% during the 3rd quarter. Schear Investment Advisers LLC now owns 4,896 shares of the healthcare conglomerate’s stock worth $2,863,000 after purchasing an additional 544 shares during the last quarter. Turtle Creek Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 13.7% during the 3rd quarter. Turtle Creek Wealth Advisors LLC now owns 2,139 shares of the healthcare conglomerate’s stock worth $1,251,000 after purchasing an additional 258 shares during the last quarter. Evergreen Wealth Management LLC increased its stake in shares of UnitedHealth Group by 28.4% during the 3rd quarter. Evergreen Wealth Management LLC now owns 2,609 shares of the healthcare conglomerate’s stock worth $1,525,000 after purchasing an additional 577 shares during the last quarter. Finally, KPP Advisory Services LLC grew its stake in UnitedHealth Group by 1.2% in the 3rd quarter. KPP Advisory Services LLC now owns 3,502 shares of the healthcare conglomerate’s stock valued at $2,048,000 after buying an additional 42 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on UNH. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Stephens reduced their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, TD Cowen boosted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Down 0.2 %

Shares of UnitedHealth Group stock opened at $592.23 on Friday. The company has a market cap of $545.02 billion, a price-to-earnings ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The company’s 50 day moving average is $582.84 and its 200 day moving average is $549.52. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $6.56 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.